Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Jul 22, 2022 4:34pm
107 Views
Post# 34844453

RE:RE:Maybe davgro can copy

RE:RE:Maybe davgro can copyHe's been exposed and I think most figured it out on the other boards (HEXO, BYL, and NDVA) just from the likes received on the post. Dumpster knows he's a joke, that's why needs multiple aliases. Along with stutters, chichi, and the rest of the frequent flyer trolls. 

davgro wrote:
Duster340 wrote: Maybe Davgro can copy and paste another comprehensive report only posted on 5 different boards today that i know of  here are 2 of the 5  he must have thought this was a good idea  (boring)


Dumpster, once again you have proved that you are a pathological liar and in need of serious psychiatric help.

Let me set the record straight;

1) contrary to your statement, I posted links to insider reports on two boards (ATE and NDVA) and not on 5 as you stated.  A simple review of my historical posts can confirm this as I do not possess the ability to delete my posts.

2) In both cases I posted those reports in response to active discussions that were taking place on those boards about insider buy/sells or holdings, so my posts were relevant to the active discussions taking place at the time.

3) The comprehensive information contained in those reports is valuable if you understand investing and doing due diligence on a company.  They may be "boring" to a penny flipping troll like you. 

Once agin you have proved your immaturity and reaffirmed what everyone on Stockhouse has posted about your behavior.  Your attempts to discredit me have only served to show everyone here your true colours.


<< Previous
Bullboard Posts
Next >>